Publicaciones (42) Publicaciones de Mattia Ghirardello

2024

  1. Correction to: Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase (Nature Communications, (2023), 14, 1, (5785), 10.1038/s41467-023-41238-1)

    Nature Communications

  2. High sensitivity profiling of N-glycans from mouse serum using fluorescent imidazolium tags by HILIC electrospray ionisation spectrometry

    Carbohydrate Polymers, Vol. 343

  3. Identification of Tumor-Linked Pancreatic Cancer Autoantibodies in Patients’ sera Through Engineered Glycopeptides

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

  4. Non-natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity

    XXIX RSEQ Biennial Meeting in Organic Chemistry: Santa Cruz de Tenerife, June 26-28, 2024: Abstract Book

  5. Non‐natural MUC1 Glycopeptide Homogeneous Cancer Vaccine with Enhanced Immunogenicity and Therapeutic Activity

    Angewandte Chemie International Edition

  6. Rational Design of Dual-Domain Binding Inhibitors for N-Acetylgalactosamine Transferase 2 with Improved Selectivity over the T1 and T3 Isoforms

    JACS Au, Vol. 4, Núm. 9, pp. 3649-3656

2023

  1. APPLICATION OF AUGMENTED REALITY IN CHEMISTRY TEACHING

    XXXIX Reunión Bienal de Química RSEQ. Libro de Abstracts

  2. Evaluation of the immunostimulant properties of carbon dot nanoparticles as carriers for cancer vaccines

    XXXIX Reunión Bienal de Química RSEQ

  3. Evaluation of the immunostimulant properties of carbon dot nanoparticles as self-adjuvating cancer vaccines

    Jornadas Posdoctorales Campus Iberus Postdoctoral Days

  4. Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models

    3rd Regular Meeting of the DIRNANO consortium

  5. Impact of structure-guided cancer nano-vaccine candidates and their respective nanoformulations in preclinical cancer models & biosensor development

    5th Regular Meeting of the DIRNANO consortium

  6. Molecular basis for bacterial N-glycosylation by a soluble HMW1C-like N-glycosyltransferase

    Nature Communications, Vol. 14, Núm. 1

  7. Multicolor Photoluminescent Carbon Dots à La Carte for Biomedical Applications

    ACS Applied Materials and Interfaces, Vol. 15, Núm. 38, pp. 44711-44721

  8. Probing the conformational behaviour of the α-C-Man-Trp in aqueous solution

    6th Glycobasque Meeting

  9. Reverse thiophosphorylase activity of a glycoside phosphorylase in the synthesis of an unnatural Manβ1,4GlcNAc library

    Chemical Science, Vol. 14, Núm. 42, pp. 11638-11646

  10. Structure-guided design of unnatural Mucin-1 biomimetics for the development of cancer therapeutic nano-vaccines and diagnostic assays

    4th Regular Meeting of the DIRNANO consortium

2022

  1. Carbon Dot-MUC1 conjugates: synthesis and applications of novel self-adjuvating cancer vaccines

    5th Glycobasque Meeting

  2. Carbon dot-based fluorescent antibody nanoprobes as brain tumour glioblastoma diagnostics

    Nanoscale Advances, Vol. 4, Núm. 7, pp. 1770-1778

  3. Carbon-based glyco-nanoplatforms: towards the next generation of glycan-based multivalent probes

    Chemical Society Reviews, Vol. 51, Núm. 24, pp. 9960-9985

  4. Recent Advances on Multivalent Carbon Nanoform-Based Glycoconjugates

    Current Medicinal Chemistry, Vol. 29, Núm. 7, pp. 1232-1257